Baytril™ Taste Tabs™ Antibacterial Tablets

Veterinary medicine · U.S. Food and Drug Administration, Center for Veterinary Medicine · United States

  • Animal drug application 140441
  • Animal drug product ID 2829

What the source publishes

Holder
Elanco US Inc.
Active ingredients
Enrofloxacin
Form
Tablet
Routes
Oral
Supply regime
RX

Names this record is found by

Complete source data
us:fda:animaldrugs:2048:2829
{
  "form": "Tablet",
  "name": "Baytril™ Taste Tabs™ Antibacterial Tablets",
  "holder": "Elanco US Inc.",
  "routes": [
    "Oral"
  ],
  "smpcUrl": null,
  "marketed": null,
  "useDomain": "veterinary",
  "leafletUrl": null,
  "supplyRegime": "RX",
  "nativeProduct": {
    "routes": [
      "Oral"
    ],
    "species": {
      "Dogs:43": "Dog, No Use Class Stated Or Implied",
      "Cats (Domestic):118": "Cat, No Use Class Stated Or Implied"
    },
    "sortOrder": 0,
    "withdrawals": [],
    "doseFormName": "Tablet",
    "applicationId": null,
    "specifications": null,
    "proprietaryName": "Baytril™ Taste Tabs™ Antibacterial Tablets",
    "proprietaryNameId": 2829,
    "statusDescription": "RX"
  },
  "nativeSummary": {
    "noohDate": null,
    "publishDate": "2026-04-06",
    "sponsorName": "Elanco US Inc.",
    "applicationId": 2048,
    "applicationType": "N",
    "proprietaryName": "Baytril™ Antibacterial Tablets\nBaytril™ Taste Tabs™ Antibacterial Tablets\n",
    "applicationNumber": 140441,
    "activeIngredientName": "Enrofloxacin\n",
    "applicationStatusCode": "A",
    "applicationStatusValue": null,
    "voluntaryWithdrawalDate": null
  },
  "targetSpecies": [
    {
      "code": "43",
      "label": "Dogs",
      "native": {
        "key": "Dogs:43",
        "population": "Dog, No Use Class Stated Or Implied"
      },
      "sourceId": "us.fda.animal-drugs",
      "population": "Dog, No Use Class Stated Or Implied",
      "canonicalId": "dog",
      "mappingStatus": "mapped",
      "mappingVersion": 1
    },
    {
      "code": "118",
      "label": "Cats (Domestic)",
      "native": {
        "key": "Cats (Domestic):118",
        "population": "Cat, No Use Class Stated Or Implied"
      },
      "sourceId": "us.fda.animal-drugs",
      "population": "Cat, No Use Class Stated Or Implied",
      "canonicalId": "cat",
      "mappingStatus": "mapped",
      "mappingVersion": 1
    }
  ],
  "informationUrl": "https://animaldrugsatfda.fda.gov/adafda/views/#/search",
  "ingredientScope": "application-level; no product-specific composition inferred",
  "nativePublishDate": "2026-04-06",
  "sourceDisposition": "reviewed-veterinary-application-product",
  "useDomainEvidence": {
    "basis": "publisher-dataset-scope",
    "field": "sourceId",
    "value": "us.fda.animal-drugs",
    "version": 1,
    "sourceId": "us.fda.animal-drugs"
  },
  "withdrawalPeriods": [],
  "patientEligibility": "not-assessed",
  "nativeApplicationId": 2048,
  "targetSpeciesStatus": "reported",
  "administrativeStatus": "unknown",
  "prescriptionCategory": "unknown",
  "activeIngredientsText": "Enrofloxacin\n",
  "nativeApplicationType": "N",
  "applicationIngredients": [
    {
      "activeIngredientName": "Enrofloxacin",
      "activeIngredientTolerance": "<p>&nbsp;A tolerance of 0.1 part per million for desethylene ciprofloxacin (marker residue) has been established in liver (target tissue) of cattle. A tolerance of 0.5 parts per million for enrofloxacin (marker residue) has been established in liver (target tissue) of swine.</p>"
    }
  ],
  "nativeApplicationNumber": 140441,
  "nativeProprietaryNameId": 2829,
  "restrictionObservations": [
    {
      "indicationText": "For management of diseases associated with bacteria susceptible to enrofloxacin.",
      "limitationText": null,
      "populationText": "Cats"
    },
    {
      "indicationText": "For management of diseases associated with bacteria susceptible to enrofloxacin.",
      "limitationText": null,
      "populationText": "Dogs"
    }
  ],
  "withdrawalPeriodsStatus": "not-reported",
  "publisherIdentityMeaning": "applicationId/proprietaryNameId are technical website keys; applicationNumber is a separate FDA application reference",
  "nativeNoticeOfHearingDate": null,
  "nativeApplicationStatusCode": "A",
  "nativeVoluntaryWithdrawalDate": null
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.animal-drugs" \
  --data-urlencode "id=us:fda:animaldrugs:2048:2829"